⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Medincell : La FDA américaine accepte le dossier de demande de mise sur le marché déposé par Teva pour l’Olanzapine LAI
businesswire.com
TEVA
Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
businesswire.com
TEVA
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
globenewswire.com
TEVA
Dactinomycin Market Research Report 2026-2030 & 2035: $7.83 Billion Market Driven by Expansion of Cancer Centers, Emphasis on Pediatric Oncology, and Combination Therapy Research
globenewswire.com
PFE
TEVA
Interact Expands its Employee Experience Platform with New AI‑Native Features and Workday Integration
globenewswire.com
LW
DPZ
TEVA
$ORCL Fraud Allegations: Oracle Corporation 11% Stock Drop Triggers Securities Fraud Class Action, Investors Notified to Contact BFA Law by April 6 to Protect Your Rights Ready to Announce with Confidence?
newsfilecorp.com
ORCL
TEVA
Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
globenewswire.com
SNY
TEVA
Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
globenewswire.com
TEVA
SNY
CoreWeave Class Action: CoreWeave, Inc. ($CRWV) Investors Are Notified of the Pending Securities Fraud Lawsuit and to Contact BFA Before the Upcoming March 13 Legal Deadline Ready to Announce with Confidence?
newsfilecorp.com
CRWV
SCZ
OPEN
TSLA
TEVA
HUBG
PFSI
PLUG
Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica
globenewswire.com
SNY
AMGN
AZN
GSK
TEVA
CHKP